WALTHAM, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its application to broaden the existing label for Feraheme (ferumoxytol injection) beyond the…Original Article
AMAG Pharmaceuticals Announces FDA Approval of Feraheme (ferumoxytol injection) for All Eligible Adult Patients with Iron Deficiency Anemia
